Female Childhood Cancer Survivors Are at Increased Risk for Breast Cancer Due to Anthracycline Treatment
Survivors of childhood cancers who were treated with anthracyclines are at increased risk for developing breast cancer.
Latest Features
LATEST ARTICLES
Real-World Data in the Era of Precision Medicine for Lymphoid Malignancies
The use of real-world data shows promise in guiding the development of management strategies for lymphoid malignancies.
A Tool to Select Candidates for Allogeneic Hematopoietic Cell Transplant in CLL
As oncologists welcome new chronic lymphocytic leukemia treatments, one researcher creates a scoring system to make the case for transplants.
New Trial Attempts to Make Genetic Counseling and Testing More Accessible
The researchers wrote that “genetic counseling must be further explored to find an optimal balance of clinical quality with increased access and financial sustainability.”
T-Cell Cryopreservation for Use in Future Cancer Treatment: Hot or Hype?
Can healthy immune cells from a patient be frozen and used in the future to make adoptive cell therapies in the event of a cancer diagnosis?
Metastatic Colorectal Cancer Treatment Options: New BRAF V600E Data
The combination of ENCO and BINI had greater antitumor activity against mCRC cells with the BRAF V600E mutation.
Prostate Cancer and Androgen Deprivation Therapy: Is There a Link to Dementia?
Patients treated with ADT for prostate cancer had a higher hazard ratio for developing Alzheimer disease than those who did not receive this therapy.
Axi-Cel Moves Toward the First-Line Setting for High-Risk Large B-Cell Lymphoma
Are patients who have received fewer prior medications better candidates for the receipt of CAR-T therapies?
The Cost of Cancer and How Health Care Providers Can Help Mitigate Financial Toxicity
A close-up look at the cost of cancer care, current legislative actions, and tools clinicians can use to help ease patients’ financial burden.
Disrupted Glucose Metabolism Led to High Levels of DNA Damage in Pancreatic Tissue: Study
A new study has suggested disrupted glucose metabolism is linked to high levels of DNA damage in the pancreas, which may contribute to the acquisition of KRAS mutations and subsequent carcinogenesis.
Do Oncologists Change Practice Based on Inadequate Evidence?
Oncologists are changing the way they treat, perhaps too quickly and with too little evidence — but the behavior may signal a bigger problem with how research is reported.
Relapsed Follicular Lymphoma: Stem Cell Transplantation in the Era of Targeted Therapies
Both autologous and allogeneic stem cell transplantation have shown benefits in patients with relapsed follicular lymphoma, but long-term data are lacking.
New Research on Anti–PD-1 Drugs Helps Fill Gaps in Knowledge on Immunotherapies in Melanoma
Oncologists lacking long-term data now have more information on relapse rates and the role of obesity in treatment success.
Biomarker Analysis Paves the Way for Targeted Therapies in Prostate Cancer
Genomic profiling reveals the prevalence of various actionable mutations in advanced prostate cancer.
PET Score Could Allow Patients to Avoid Unnecessary Treatment for Hodgkin Lymphoma
Interpreting PET scores according to established criteria is crucial for guiding treatment following initial chemotherapy in early-stage disease.
Want to read more?
Please login or register first to view this content.
